Robert W. Baird Cuts Maravai LifeSciences (NASDAQ:MRVI) Price Target to $9.00
Maravai LifeSciences (NASDAQ:MRVI – Get Free Report) had its price target lowered by stock analysts at Robert W. Baird from $10.00 to $9.00 in a report released on Friday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W. Baird’s price objective would indicate a potential upside of 77.34% from the company’s […]
More Stories
Nuwellis (NASDAQ:NUWE) Issues Quarterly Earnings Results, Beats Estimates By $2.62 EPS
Nuwellis (NASDAQ:NUWE – Get Free Report) posted its quarterly earnings data on Monday. The company reported $1.74 EPS for the...
JPMorgan Global Select Equity ETF (NASDAQ:JGLO) Short Interest Update
JPMorgan Global Select Equity ETF (NASDAQ:JGLO – Get Free Report) was the target of a significant decline in short interest...
Short Interest in Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) Decreases By 98.7%
Lipella Pharmaceuticals Inc. (NASDAQ:LIPO – Get Free Report) was the target of a large decline in short interest during the...
J. Alberto Arias Sells 18,926 Shares of Sierra Metals Inc. (TSE:SMT) Stock
Sierra Metals Inc. (TSE:SMT – Get Free Report) Director J. Alberto Arias sold 18,926 shares of the company’s stock in...
Michael Todd King Sells 1,500 Shares of PROG Holdings, Inc. (NYSE:PRG) Stock
PROG Holdings, Inc. (NYSE:PRG – Get Free Report) insider Michael Todd King sold 1,500 shares of the stock in a...
Angi (NASDAQ:ANGI) Announces Earnings Results
Angi (NASDAQ:ANGI – Get Free Report) posted its earnings results on Monday. The technology company reported $0.07 EPS for the...